RadNet (RDNT) Stock: Buy, Sell, or Hold?
$77.94
-0.44 (-0.56%)
▼
5d:
+6.5%
30d:
+9.02%
90d:
+1.29%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (32%)
Quality Score
38/100
Position
EXTENDED
30-Day Fair Range
$68.54 – $74.24
Position: EXTENDED
Forward P/E & Valuation
95.1x
STRETCHED
vs 75.2x historical avg
Wall Street Target
$94.63
+21.4% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$71.91 / $81.87
Trend: Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: RDNT shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When RDNT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$39.92
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$24.79
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: RDNT is currently trading at $77.94, which is considered extended relative to its 30-day fair value range of $68.54 to $74.24. From a valuation perspective, the stock is trading at a premium (Forward PE: 95.0) compared to its historical average (75.2). At these levels, the market is pricing in 8.1% annual earnings growth.
Technical Outlook: Technically, RDNT is in a uptrend. Immediate support is located at $71.91, while resistance sits at $81.87.
Market Sentiment: RDNT scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $94.62 (+21.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, RDNT is in a uptrend. Immediate support is located at $71.91, while resistance sits at $81.87.
Market Sentiment: RDNT scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $94.62 (+21.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$68.54 -
$74.24
Company Quality Score
38/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
31.9%
Trading Range & Key Levels
30-Day Trading Range
$68.54 -
$74.24
Current vs Trading Range
EXTENDED
Support Level
$71.91
Resistance Level
$81.87
Current Trend
Uptrend
Technical data as of
Nov 10, 2026
Protect Your Profits
Holding RDNT? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (0/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 21.4% below Wall St target ($94.62)
- BULLISH: Expecting earnings turnaround to 8.1% growth with 22.1% revenue growth
- WARNING: Composite score 38/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
95.05
Wall Street Target
$94.63
(+21.4%)
Revenue Growth (YoY)
22.1%
Earnings Growth (YoY)
-28.6%
Profit Margin
-0.9%
Valuation Premium vs History
+8.1% premium
PE vs Historical
95.1 vs 75.2
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+8.1%
(market-implied from PE analysis)
1-Year Target
$84.25
(+8%)
2-Year Target
$91.08
(+17%)
3-Year Target
$98.45
(+26%)
3-Yr Target (if PE normalizes)
(PE: 95→75)
PE COMPRESSION
$77.89
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 95.0, Growth: 59.4%)
$263.05
(+238%)
Base:
(SPY PE: 19.9, Growth: 59.4%)
$54.96
(-30%)
Bear:
(PE: 16.9, Growth: 59.4%)
$46.72
(-40%)
Share RDNT Analysis
Share this live RDNT analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (RDNT)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Aug 11, 2026
Daily AI digest
AI Retail Discussion Summary:
RadNet reported strong Q2 results with record revenue and adjusted EBITDA driven by higher imaging volumes, acquisitions, and growth in advanced imaging procedures and Digital Health segment.
Key Retail Themes:
Higher demand for advanced imaging procedures
Growth in Digital Health segment
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 10, 2026 9:20 PM ET
Data refreshes hourly during market hours. Next update: 10:20 PM
Data refreshes hourly during market hours. Next update: 10:20 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RDNT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
GH
Guardant Health Inc |
STRONG BUY
26 analysts |
$201 | 52 HOLD |
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
27 analysts |
$752 | 54 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 52 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
23 analysts |
$416 | 58 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
24 analysts |
$260 | 56 HOLD |
Advanced RDNT Option Strategies
Professional options setups generated by AI based on today's RDNT price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive RDNT Research Pages
